Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0107-2027

SEDIPLAST; Model/Catalog Numbers: S-100 and S-1000; Recall

SEDIPLAST; Model/Catalog Numbers: S-100 and S-1000;

FDA recall Class II

Ongoing

FDA lists this Class II recall for SEDIPLAST; Model/Catalog Numbers: S-100 and S-1000;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0107-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 25, 2026
FDA report date
Oct 14, 2026
Quantity in commerce
448400
Distribution
See key details
FDA cause
Process control

What is being recalled?

SEDIPLAST; Model/Catalog Numbers: S-100 and S-1000;

Affected model & UDI checker

Search the exact identifiers published for Z-0107-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
S-100SEDIPLAST; Model/Catalog Numbers: S-100 and S-1000;Check source noticeNot specified
S-1000SEDIPLAST; Model/Catalog Numbers: S-100 and S-1000;Check source noticeNot specified
FDA code information

Model/Catalog No. S-100 and S-1000; UDI-DI: N/A; Lot Number E1150A; Expiration Date 06/30/27

View the original FDA recall notice

Why was this product recalled?

During use of an affected tube, the operator may encounter increased resistance when inserting the pipette. The resulting pressure buildup may cause the tube cap to detach or be forcibly ejected, potentially resulting in the release of blood and exposure of the operator or surrounding work area to a biological hazard (blood).

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did POLYMEDCO, INC. / POLYMEDCO CANCER DIAGNOSTIC PRODUCTS, LLC take?

On August 26, 2026, URGENT PRODUCT RECALL letters were sent to customers. ACTIONS REQUIRED: 1. Examine your inventory and identify all Sediplast Westergren ESR tubes from Lot E1150A. 2. Immediately discontinue use and quarantine all unused tubes from the affected lot. 3. If affected product was distributed to other facilities or locations, immediately forward this notification to those recipients. 4. Contact Polymedco Technical Services to arrange replacement of the affected product and obtain instructions for its return or disposal. 5. Complete and return the enclosed Customer Recall Response Form to Polymedco within five business days, even if you no longer have any affected product in inventory. 6. If affected tubes were previously used without an incident, no additional action is required. If a cap-ejection, blood-spray or exposure incident occurred, follow your facility s applicable biohazard-exposure procedures and report the incident to Polymedco Technical Services. Please do not discard quarantined product until you have received return or disposal instructions from Polymedco.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology